{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-032384","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2024-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.026252+00:00","generated_at":"2026-06-05T00:27:30.837385+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SELLAS terminates EVP General Counsel and SVP Chief Commercial Officer; reorganizes leadership","bullets":["Barbara Wood (EVP, GC, Corp Secretary) terminated without cause, effective April 15, 2024.","Robert Francomano (SVP, Chief Commercial Officer) terminated without cause, effective March 31, 2024.","Company streamlines leadership, engages commercial consultant for partnerships; Stacy Yeung promoted to VP legal/compliance.","CEO reaffirms focus on Phase 3 REGAL interim analysis and SLS009 topline data in Q1/Q2 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-032384","json":"https://secwatch.observer/filing/0001104659-24-032384.json","markdown":"https://secwatch.observer/filing/0001104659-24-032384.md","text":"https://secwatch.observer/filing/0001104659-24-032384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924032384/0001104659-24-032384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924032384/tm248331d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:27:30.837385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10106a5e01","claim":"Robert Francomano was terminated as Senior Vice President and Chief Commercial Officer at SELLAS Life Sciences Group, Inc..","evidence_excerpt":"In addition, on March 6, 2024, Robert Francomano, Senior Vice President and Chief Commercial Officer of the Company, was terminated without cause, effective March 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924032384/0001104659-24-032384-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Senior Vice President and Chief Commercial Officer"}],"fact_type":"executive_change"},{"claim_id":"90a6a70ee5","claim":"Barbara A. Wood was terminated as Executive Vice President, General Counsel and Corporate Secretary at SELLAS Life Sciences Group, Inc..","evidence_excerpt":"On March 6, 2024, Barbara A. Wood, Executive Vice President, General Counsel and Corporate Secretary of SELLAS Life Sciences Group, Inc. (the “Company”), was terminated without cause, effective April 15, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924032384/0001104659-24-032384-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Executive Vice President, General Counsel and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}